Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort ascending
May
6
2011
Oracle Ordered to Reduce the Number of Patent Infringement Claims against Google Schwegman, Lundberg & Woessner, P.A.
Dec
28
2020
China to Establish Fourth Intellectual Property Court at Hainan Free Trade Port Schwegman, Lundberg & Woessner, P.A.
Jan
11
2021
American Axle Petitions for Cert. Schwegman, Lundberg & Woessner, P.A.
Jun
23
2011
Supreme Court Grants Cert. In Mayo v. Prometheus Schwegman, Lundberg & Woessner, P.A.
Jan
31
2021
China National Intellectual Property Administration to Close February 11, 2021 – February 17, 2021 for Chinese New Year Schwegman, Lundberg & Woessner, P.A.
Feb
14
2021
China’s Supreme People’s Procuratorate Issues 26th Batch of Guiding Cases for Intellectual Property Schwegman, Lundberg & Woessner, P.A.
Mar
5
2021
The Intellectual Property Tribunal of China’s Supreme People’s Court Released Top 10 Cases of Technical Intellectual Property Rights in 2020 Schwegman, Lundberg & Woessner, P.A.
Mar
11
2021
Chinese Provincial Intellectual Property Offices Crack Down on “Irregular” Patent Applications; 400,000 Chinese Patent Applications to be Withdrawn as Irregular? Schwegman, Lundberg & Woessner, P.A.
Apr
3
2021
Guangdong Higher People’s Court Ups Damages 10X on Appeal in Trademark Infringement Case for Lego Bricks Schwegman, Lundberg & Woessner, P.A.
Feb
28
2012
Bayer v. Lupin – Patenting The Label Redux Schwegman, Lundberg & Woessner, P.A.
Apr
27
2021
Guest Post: Well-Know Mark Recognitions in China – Part IV Schwegman, Lundberg & Woessner, P.A.
Jul
9
2015
Intellectual Ventures I v. Capitol One Bank: Mental Steps Doctrine Making Strong Comeback, Courtesy of Alice Schwegman, Lundberg & Woessner, P.A.
Mar
29
2012
Legal Challenge To “ObamaCare” Threatens Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
May
31
2021
Per CNIPA, 43% of Chinese Patent Firms Have Submitted ‘Irregular’ Patent Applications Schwegman, Lundberg & Woessner, P.A.
May
24
2012
Prometheus Unbound – Are Methods Of Medical Treatment The Next “Targets”? Schwegman, Lundberg & Woessner, P.A.
Jun
28
2012
“Obamacare” Survives – Including Path to Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
Jul
11
2012
“In Leukemia Treatment, Glimpses of the Future” of Medicine and IP Schwegman, Lundberg & Woessner, P.A.
Sep
3
2015
Another Claim Bites the Dust left by Teva v. Sandoz Schwegman, Lundberg & Woessner, P.A.
Nov
16
2012
Bard v. Gore: Joint Inventors or Just One? Schwegman, Lundberg & Woessner, P.A.
Oct
16
2021
CareDx v. Natera – Are Processing Steps Known to the Art Always “Conventional”? Schwegman, Lundberg & Woessner, P.A.
Oct
31
2021
China Sentences Shoe Polish Counterfeiters to Up To 3 Years in Prison in Criminal Trademark Case Schwegman, Lundberg & Woessner, P.A.
Jan
20
2013
USPTO Publishes Final Rules for Micro-Entity Status and Fee Schedule Schwegman, Lundberg & Woessner, P.A.
Feb
22
2013
Is Software Different than other Technologies? Yes and No Schwegman, Lundberg & Woessner, P.A.
Feb
2
2022
China’s National Intellectual Property Administration Releases 2021 Results for the Blue Sky IP Agency Rectification Campaign Schwegman, Lundberg & Woessner, P.A.
Apr
9
2013
NOVARTIS A.G. v. UOI – What is Novelty in Indian Courts? Schwegman, Lundberg & Woessner, P.A.
Apr
25
2013
Patent Trial and Appeal Board Inter Partes Review (IPR) Petition Joinder Practice Gains Momentum Schwegman, Lundberg & Woessner, P.A.
Jun
8
2022
China’s National Intellectual Property Administration Announces Record 2.49 Million RMB Fine Against Patent Firm for Unauthorized Practice of Law and Filing Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
Sep
1
2013
WildTangent Files its Supreme Court Certiorari Petition in Patent Infringement Case – Part 1 Schwegman, Lundberg & Woessner, P.A.
Jul
28
2022
Even the Chinese Government isn’t Safe from Counterfeiters: China Cracks Down on Counterfeit Mail Trucks Schwegman, Lundberg & Woessner, P.A.
Aug
24
2022
20,000 RMB for Passing Chinese Patent Bar in Guangzhou Schwegman, Lundberg & Woessner, P.A.
Oct
18
2013
Another Software Patent Horror Story Unmasked and Debunked: This One You Won’t Believe Schwegman, Lundberg & Woessner, P.A.
Aug
29
2022
Supreme People’s Court Upholds China’s First Patent Linkage Ruling – Decision Released Schwegman, Lundberg & Woessner, P.A.
Nov
2
2013
Novozymes Looses “Possession” Of Its Enzyme Re: Patent Litigation Schwegman, Lundberg & Woessner, P.A.
Apr
11
2016
The Biggest Technology Give-Away in History? Schwegman, Lundberg & Woessner, P.A.
Apr
26
2016
Myriad vs. Mayo – Detection vs. Processing at the Federal Circuit Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins